![](https://www.arthurcox.com/wp-content/uploads/2019/12/LM_ACDR_2197-1-768x576.jpg)
![](https://www.arthurcox.com/wp-content/themes/arthur-cox/assets/images/placeholders/landscape_4.jpg)
Strongbridge Biopharma plc acquisition by Xeris Pharmaceuticals, Inc
![](https://www.arthurcox.com/wp-content/themes/arthur-cox/assets/images/placeholders/portrait_1.jpg)
25/05/2021
Deals
Arthur Cox was very pleased to advise Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company, on its recommended acquisition by Xeris Pharmaceuticals, Inc.
The Arthur Cox team was led by Maura McLaughlin (Corporate and M&A) and included Conor O’Keeffe, Andrea Bowdren and Patrick Munnelly (Corporate and M&A) and Fintan Clancy and Nicola Cavey (Tax).